Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    11850858 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Caspofungin or Micafungin as Empiric Antifungal Therapy for Persistent Fever and Neutropenia
Condition: Febrile Neutropenia
Intervention:
2 Completed Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation
Conditions: Allogenic Blood Stem Cell Transplantation;   Febrile Neutropenia
Interventions: Drug: Meropenem;   Drug: Vancomycin;   Drug: Teicoplanin
3 Terminated Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia
Conditions: Malignant Hemopathy;   Duration of Neutropenia Following Chemotherapy > 10 Days
Intervention: Drug: Amphotericin B

Indicates status has not been verified in more than two years